Business Context and Reporting Period
This Form 8-K reports on the results of the reconvened 2025 Annual Meeting of Stockholders for iSpecimen Inc., held on May 29, 2026. The company is an emerging growth company incorporated in Delaware, with its principal executive offices in Woburn, MA. The filing details the voting outcomes for three specific proposals presented to shareholders.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting. It does not provide financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the company's most recent Form 10-K or 10-Q for financial performance details.
Material Changes and Voting Results
The filing documents the following shareholder actions taken at the Annual Meeting:
- Quorum: A quorum was established with 2,979,059 shares present or represented by proxy, representing approximately 35.14% of the 8,478,579 eligible shares.
- Proposal 1 (Director Election): Arphing (Tommy) Lee was elected as a Class I Director for a three-year term.
- For: 562,361
- Withheld: 150,431
- Broker Non-Vote: 2,266,267
- Proposal 2 (Auditor Ratification): The appointment of Bush & Associates CPA LLC as the independent registered public accounting firm for the year ending December 31, 2025, was ratified.
- For: 2,424,420
- Against: 155,256
- Abstain: 399,383
- Proposal 3 (Stock Incentive Plan): The iSpecimen Inc. 2025 Stock Incentive Plan was approved.
- For: 461,073
- Against: 186,740
- Abstain: 64,979
- Broker Non-Vote: 2,266,267
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly reports the administrative outcomes of the shareholder meeting.
Key Facts for Investor Verification
- Verify the total number of shares eligible to vote (8,478,579) against the company's latest capitalization table.
- Note the significant number of broker non-votes (2,266,267) on the director election and stock incentive plan, indicating shares held in street name where brokers lacked discretionary voting power.
- Confirm the term expiration for the newly elected director (Class I) is set for the 2028 Annual Meeting.
- Review the definitive proxy statement filed on November 21, 2025, for detailed descriptions of the proposals and the rationale behind the 2025 Stock Incentive Plan.